Inderpal Randhawa, MD

Dr. Randhawa is a leading clinical academic scientist with five board certifications in transplant immunology, allergy, pulmonology, pediatrics, and internal medicine. He is the Founder, CEO, and Chief Medical Officer of the Translational Pulmonary & Immunology Research Center (TPIRC), a nonprofit corporation located in Long Beach, California, which utilizes applied math, data analytics, biomarker development, and artificial intelligence to treat patients suffering from orphan diseases. Dr. Randhawa is also the founder of TPIRC's allergy division, the Food Allergy Institute, an organization that has successfully induced remission in over 12,000 patients suffering from life-threatening food anaphylaxis. Dr. Randhawa received his medical degree from Northwestern University's Feinberg School of Medicine. After completing a combined internal medicine/pediatrics residency, he completed training in Clinical Immunology & Allergy at UCLA and pediatric and adult pulmonology at UC Irvine – Miller Children's Hospital. Dr. Randhawa has authored over 150 peer-reviewed abstracts, presentations, and research publications and has served as a primary investigator in over 25 clinical trials.